By Randi Belisomo NEW YORK (Reuters Health) - The Centers for Medicare and Medicaid Services met Wednesday with 30 hospice and healthcare organizations after outcry over a new rule. The rule was designed to help avoid duplicate payments for hospice medications but may be having unintended consequences. Signed by the American Medical Association, the American Society of Clinical Oncology and the American Geriatrics Society, it argues the policy places “undue burden” on beneficiaries - requiring “dying patients to navigate payer disputes.” Previously, hospices paid only for the drugs patients needed for symptom management, and Medicare Part D drug policies covered drugs for hospice patients’ unrelated conditions. Under the new rule, CMS now requires a prior authorization process for hospices and Part D providers to determine responsibility of drug coverage, and hospices must cover medications not related to the hospice diagnosis. via Health News Headlines - Yahoo News Read More Here..
Lake forest health and fitness http://ift.tt/1qeOUGr
No comments:
Post a Comment